About Qualitate

Qualitate is building the AI-native primary intelligence platform for enterprises, investment firms, and asset managers. We automate the entire primary research workflow, from study design and expert recruitment through AI-moderated interviews and insight synthesis - replacing weeks of manual research with hours of high-signal output.

Expert research is a broken industry dominated by legacy incumbents with expensive, manual, and slow services. Investment and corporate strategy teams spend hundreds of hours coordinating intermediaries, scheduling expert calls, and synthesizing insights across fragmented providers. The process takes weeks to produce short-lived intelligence.

Qualitate transforms this workflow by autonomously conducting expert discussions at scale using AI. Qualitate’s AI Moderator interviews thousands of experts simultaneously each month, capturing forward-looking purchasing plans, competitive displacement, and real-time ROI signals. The platform turns these interviews into quantified, time-series outputs tracking over 10,000 public and private companies, queryable instantly in natural language. Our customers include some of the world’s largest enterprises, hedge funds, PE firms, credit investors, and venture capital firms.

The Role

Primary research is a core workflow in biotech and biopharma. Diligence, forecasting, and product decisions all run through what practitioners, payers, and buyers are seeing - but that process faces a major scalability bottleneck. We've already solved this bottleneck in several other industries, and demand from the biotech and biopharma market has been loud enough that we're now running the same playbook here.

Reporting to the Director of Research, you'll shape the biotech and biopharma research roadmap, decide what we cover and when, determine the most pertinent questions and KPIs, and publish the insights that establish this coverage in the market. You'll be in front of investors and corporate teams, and you'll be accountable for the outcomes: the quality of the research, its predictive accuracy, and the reputation of Qualitate's biotech and biopharma franchise.

What the day-to-day looks like

• Leverage the company's proprietary datasets to uncover insightful company and market trends across biotech and biopharma services, medtech, and pharma/biotech for investment funds and corporate clients.

• Develop forward-looking analyses and uncover industry dynamics, key growth drivers, and demand shifts across key biotech and biopharma.

• Contribute thought leadership by creating high-impact content for our newsletter and client communications.

• Clearly and effectively communicate actionable insights to clients and prospects through calls, webinars, and events.

• Contribute domain expertise and research judgement to hone the fidelity of our first-to-market research methodology; partner with product and engineering teams on design to continue the creation of our best-in-class AI-native research platform.

• Stay ahead of emerging trends, technologies, and innovators shaping the future of biotech and biopharma.

Who This Role Is For

• 3+ years professional experience in data-driven research creation. Equity research, financial analysis, market research, and/or consulting roles.

• You understand the fundamental research workflow. How funds source ideas and build conviction through data and primary research. You can articulate how Qualitate fits into that process in the terms buyers actually care about. You know which metrics matter to biotech and biopharma investment decisions.

• In-depth knowledge of key Healthcare & Life Science sectors including Pharma, Biotech, Medical Devices, Healthcare Services, Managed Care, Life Science Tools, Digital Health, Health Tech, and emerging fields.

• You communicate your ideas clearly. Long-form and short-form writing expertise required - you must be able to synthesize data into digestible, forward-looking insights. You should feel comfortable talking to investors and corporate clients as an authority on biotech and biopharma.